US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about NASDAQ:RNXT

Recent news which mentions NASDAQ:RNXT

RNXT Stock Earnings: RenovoRx Meets EPS for Q2 2024
Tickers RNXT
Tags NASDAQ:RNXT RNXT Market News
From InvestorPlace
RNXT Stock Earnings: RenovoRx Beats EPS for Q1 2024
Tickers RNXT
Tags Earnings Reports Market News NASDAQ:RNXT
From InvestorPlace
RNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023
Tickers RNXT
Tags NASDAQ:RNXT RNXT Market News
From InvestorPlace
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
Tickers IMU RNXT
Tags NASDAQ:RNXT
From News Direct
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
Tickers RNXT
Tags NASDAQ:RNXT
From News Direct
RenovoRx’s Principal Investigator of Phase III Clinical Trial Discusses Positive Interim Results on Patients with Locally Advanced Pancreatic Cancer on OncologyTube
Tags NASDAQ:RNXT
From News Direct
RenovoRX's Latest Innovative Technology Creates New Hope For Chemotherapy Patients
Tags NASDAQ:RNXT
From News Direct